We previously found that the FLT3 inhibitors sorafenib and sunitinib blocked the signalling pathways of tumour cell proliferation and induced apoptosis of nasopharyngeal carcinoma cells [22]. The gene discussed is FLT3; the disease is nasopharyngeal carcinoma.